We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1301
Summit Hotel Properties
INN
$746M
| $3.08M | 0.01% |
192,894
+59,247
| +44% | +$933K |
|
|
DMC
1302
Del Monte Corp
DMC
$1.41B
| $3.07M | 0.01% |
51,757
+1,088
| +2% | +$63.9K |
|
1303
Greif
GEF
$4.92B
| $3.05M | 0.01% |
55,432
+1,780
| +3% | +$98.9K |
|
|
MTSC
1304
DELISTED
MTS Systems Corp
MTSC
| $3.05M | 0.01% |
55,478
+2,154
| +4% | +$121K |
|
|
EXAS
1305
DELISTED
Exact Sciences
EXAS
| $3.05M | 0.01% |
129,210
+2,552
| +2% | +$50.6K |
|
|
SEMG
1306
DELISTED
SEMGROUP CORPORATION
SEMG
| $3.04M | 0.01% |
84,508
+3,001
| +4% | +$114K |
|
|
AIRM
1307
DELISTED
Air Methods Corp
AIRM
| $3.03M | 0.01% |
70,516
+16,822
| +31% | +$650K |
|
|
SUM
1308
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.03M | 0.01% |
126,513
+37,091
| +41% | +$870K |
|
1309
Albany International
AIN
$2.11B
| $3.03M | 0.01% |
65,748
+15,893
| +32% | +$739K |
|
1310
Badger Meter
BMI
$3.89B
| $3.02M | 0.01% |
82,292
+41,520
| +102% | +$1.53M |
|
|
USG
1311
DELISTED
Usg
USG
| $3.02M | 0.01% |
94,889
+5,195
| +6% | +$165K |
|
1312
Boston Beer
SAM
$1.91B
| $3.02M | 0.01% |
20,843
+714
| +4% | +$112K |
|
|
HZNP
1313
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.02M | 0.01% |
203,972
+7,766
| +4% | +$126K |
|
|
ESGR
1314
DELISTED
Enstar Group
ESGR
| $3.01M | 0.01% |
15,716
+517
| +3% | +$100K |
|
1315
Adtran
ADTN
$689M
| $3M | 0.01% |
144,512
+16,730
| +13% | +$363K |
|
1316
Brown-Forman Class A
BF.A
$13.4B
| $3M | 0.01% |
79,590
+14,492
| +22% | +$551K |
|
1317
Liberty Broadband Class A
LBRDA
$4.89B
| $3M | 0.01% |
35,203
+1,360
| +4% | +$112K |
|
|
AFSI
1318
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $2.99M | 0.01% |
162,024
-3,888
| -2% | -$94.7K |
|
1319
Omnicell
OMCL
$1.61B
| $2.99M | 0.01% |
73,534
+20,618
| +39% | +$760K |
|
1320
Four Corners Property Trust
FCPT
$2.81B
| $2.99M | 0.01% |
130,819
+36,154
| +38% | +$776K |
|
1321
AMERISAFE
AMSF
$543M
| $2.98M | 0.01% |
46,001
+9,986
| +28% | +$642K |
|
|
CUB
1322
DELISTED
Cubic Corporation
CUB
| $2.98M | 0.01% |
56,480
+14,607
| +35% | +$737K |
|
1323
SouthState Bank Corp
SSB
$10.2B
| $2.98M | 0.01% |
33,337
+3,132
| +10% | +$277K |
|
1324
Opko Health
OPK
$985M
| $2.98M | 0.01% |
372,250
+14,377
| +4% | +$121K |
|
|
QTS
1325
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.97M | 0.01% |
60,854
+4,605
| +8% | +$231K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.